PA
INDP icon

Perceptive Advisors’s Indaptus Therapeutics INDP Stock Holding History

Perceptive Advisors’s Portfolio INDP Stock Details INDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-86
Closed -$795K – 191
2016
Q1 		$795K Sell
86
-37
-30% -$344K 0.07% 105
2015
Q4 		$1.47M Sell
123
-33
-21% -$424K 0.11% 80
2015
Q3 		$1.96M Buy
+156
New +$2.05M 0.16% 82

Other funds holding INDP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Perceptive Advisors's INDP Position: Q2 2016 in Review

Perceptive Advisors sold out of Indaptus Therapeutics (INDP) in Q2 2016, closing a stake of 86 shares — an estimated $795K sold.

Perceptive Advisors first reported a position in INDP in Q3 2015 and held it in 3 quarters. The position peaked at $1.96M in Q3 2015. 6 funds tracked by Wall St. Rank hold INDP as of Q2 2016.

  • Perceptive Advisors reported no remaining Indaptus Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Perceptive Advisors sold 86 Indaptus Therapeutics shares in Q2 2016, an estimated $795K.
  • Perceptive Advisors first reported a position in Indaptus Therapeutics in Q3 2015 and held it in 3 quarters.
  • Perceptive Advisors's Indaptus Therapeutics position peaked at $1.96M in Q3 2015.
  • 6 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q2 2016.

Based on Perceptive Advisors's 13F filing for Q2 2016, filed 11 Aug 2016.